Timolumab (BTT1023), a fully human monoclonal antibody, selectively targets VAP-1 and has potential applications in investigating chronic inflammatory diseases [1] [2].
CAS Number:
[1073538-99-4]
* VAT and and shipping costs not included. Errors and price changes excepted
